Science

Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin

Susan F. Slovin/mskcc.org

Mar 24, 2025, 10:41

Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin

Ravi A Madan, Clinical researcher at the National Cancer Institute, shared an article by Susan F. Slovin, et al. on X:

“Dr. Susan Slovin Memorial Sloan Kettering Cancer Center asks some key questions regarding Prostate Cancer.

Immune Checkpoint Combos in mCRPC: Where Are We Going, What Are We Doing, and Why?”

Immune Checkpoint Combos in Metastatic Castration-Resistant Prostate Cancer: Where Are We Going, What Are We Doing, and Why?

Authors: Susan F. Slovin, et al.

Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin

cancer fight against cancer Global fight against cancer Immune Checkpoint mCRPC Memorial Sloan Kettering Cancer Center metastatic castration-resistant prostate cancer National Cancer Institute NCI OncoDaily Oncology prostate cancer Ravi A. Madan Susan F. Slovin

Does Vaping Cause Lung Cancer? Myths and Facts

James Van Der Beek: Battle with Colorectal Cancer and Marriage Challenges During Treatment

FDA approval: Pembrolizumab for HER2 positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥1): KEYNOTE-811 Trial

Changing the Future of Adolescent and Young Adult Cancer Care

OncoDaily Launches New Social Channel on Telegram – @OncoDaily